Clinical Research Fellow (ST3+) Medical Oncology

at  University College London Hospitals NHS Foundation Trust

Applications are invited for the post of Clinical Research Fellow in Cancer Drug Development. The aim of this position is to offer comprehensive specialist training in all aspects of running early phase oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings. Support and opportunities for pursuing higher research degrees are also available.
These full-time posts are available from February 2024 and August 2024 and will be for a period of up to 12 months in the first instance and there is potential opportunity to extend beyond 12 months. Applicants must demonstrate as part of their application, how they meet the essential requirements of the post. In particular, applicants should have a medical degree and GMC registration. Experience in oncology and clinical research are an advantage. Fluency in English and aptitude with writing and publishing manuscripts are essential

FOR FURTHER DETAILS / INFORMAL VISITS CONTACT:

Dr Martin Forster via martin.forster1@nhs.net or Dr Rakesh Popat at rakesh.popat@nhs.net
The aim of this position is to offer comprehensive specialist training in all aspects of running early phase oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
National Hospital for Neurology and Neurosurgery
Royal National ENT and Eastman Dental Hospitals
University College Hospital Grafton Way Building
Royal London Hospital for Integrated Medicine
University College Hospital Macmillan Cancer Centre
The Hospital for Tropical Diseases
University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
At UCLH, we have a real ‘One Team’ ethos, and our values – safety, kindness, teamwork and improving, are central to the way we work. This is supported by our staff, who voted us as the #1 NHS Acute Trust to work for in the whole of England.
This post would be particularly suitable for a trainee who intends to pursue an academic oncology career with an interest in translational research and drug development. However the post also will provide important training in generic and transferable skills for non-academic trainee.
The NIHR UCLH Clinical Research Facility (CRF) opened in February 2009 on the Ground Floor of Elizabeth Garrett Anderson Wing of UCH, in the heart of Bloomsbury and is now located in a purpose built location on Tottenham Court Road.
It is a partnership between University College London (UCL) and University College London Hospitals (UCLH) NHS Foundation Trust. The facility is funded principally by the National Institute of Health Research (NIHR).
The CRF is also supported by funding from Cancer Research UK and the Experimental Cancer Medicine Centre (ECMC). It has a remit to progress high quality clinical research in any domain but with a specific focus on early-phase clinical trials and experimental medicine
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For more information regarding the main responsibilities of the role, please refer to the attached Job Description

Please refer the Job description for details